Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
19,704.33
+30.00
0.15%
Nifty
5,983.55
+16.50
0.28%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Glaxosmithkline Pharma Ltd
BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016
Market Cap: [Rs.Cr.] 19,207 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Multinational
Discuss this stock
Sector News
No Sector News
India Infoline Research
Company
|
Sectors
GlaxoSmithKline Pharma: Call Closure
Conviction Sell Ideas
Related News
Company
|
Sector
|
Latest
07-May-13
GlaxoSmithKline Pharmaceuticals
07-May-13
Glaxosmithkline Pharma net profit rises 37.53% in the March 2013 quarter
07-May-13
GSK Pharma holds firm at higher levels after Q1 earnings
07-May-13
GSK Pharma hits record high ahead of Q1 results
25-Apr-13
GlaxoSmithKline Pharmaceuticals to announce Q1 results
18-Apr-13
Pharmaceuticals Newsletter - 15 April to 18 April, 2013
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Glaxosmit Pharma
19,207.00
29.02
9.56
18.86
34.3
45.2
0.00
Sanofi India
5,688.41
31.44
4.77
13.73
15.4
22.5
0.00
Pfizer
3,126.19
15.17
1.83
9.41
15.0
22.1
0.00
Abbott India
3,070.09
18.49
4.75
12.08
24.3
34.8
0.00
Fres.Kabi Onco.
1,976.71
22.04
3.34
22.38
3.5
5.4
0.42
Wyeth
1,771.48
13.62
3.09
7.61
33.4
45.1
0.01
Astrazeneca Phar
1,729.88
0.00
17.34
140.28
10.7
15.2
0.03
Novartis India
1,597.68
13.34
1.77
10.43
20.0
28.8
0.00
Merck
1,079.08
13.49
2.23
7.04
17.5
25.5
0.00
Fulford (India)
247.65
0.00
1.71
0.00
-3.4
-4.7
0.00
Organon (India)
159.14
0.00
0.98
0.00
15.3
22.8
0.00
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
D S Parekh , Chairman
V Thyagarajan , Vice Chairman
H B Joshipura , Managing Director
R R Bajaaj , Director
Company Head Office / Quarters:
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Phone : 91-022-24959595
Fax : 91-022-24959494
E-mail :
ajay.a.nadkarni@gsk.com
Web :
http://www.gsk-india.com
Registrars:
Karvy Computershare Pvt Ltd
Plot No 17-24
Vittal Rao Nagar
Madhapur
Hyderabad-500081
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
UTI-Dividend Yield Fund (G)
450,000
Franklin India Bluechip Fund - (G)
250,000
Reliance Pharma Fund (Bonus)
187,900
Detailed List
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
Issue Open :
India Finsec
View full month IPO calendar
Economic Events
No economic event today
View full month Economic Events calendar
Results
Bharat Forge | Oil India | Container Corpn.
View full month Results calendar